Local anesthesia versus general anesthesia during endovascular therapy for acute stroke: a propensity score analysis.


Journal

Journal of neurointerventional surgery
ISSN: 1759-8486
Titre abrégé: J Neurointerv Surg
Pays: England
ID NLM: 101517079

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 19 02 2020
revised: 24 03 2020
accepted: 02 04 2020
pubmed: 4 6 2020
medline: 27 4 2021
entrez: 4 6 2020
Statut: ppublish

Résumé

To date, the choice of optimal anesthetic management during endovascular therapy (EVT) of acute ischemic stroke patients remains subject to debate. We aimed to compare functional outcomes and complication rates of EVT according to the first-line anesthetic management in two comprehensive stroke centers: local anesthesia (LA) versus general anesthesia (GA). Retrospective analysis of prospectively collected databases, identifying all consecutive EVT for strokes in the anterior circulation performed between January 1, 2018 and December 31, 2018 in two EVT-capable stroke centers. One center performed EVT under LA in the first intention, while the other center systematically used GA. Using propensity score analysis, the two groups underwent 1:1 matching, then procedural metrics, complications, and clinical outcomes were compared. Good outcome was defined as 90 days modified Rankin Scale (mRS) ≤2, and successful recanalization as modified Thrombolysis In Cerebral Ischemia (mTICI) 2b-3. During the study period, 219 patients were treated in the LA center and 142 in the GA center. Using the propensity score, 97 patients from each center were matched 1:1 according to the baseline characteristics. Local anesthesia was associated with a significantly lower proportion of good outcome (36.1% vs 52.0%, OR 0.53, 95% CI 0.33 to 0.87; p=0.039), lower rate of successful recanalization (70.1% vs 95.8%, OR 0.13, 95% CI 0.04 to 0.39; p<0.001), and more procedural complications (14.4% vs 3.0%, OR 3.44, 95% CI 1.09 to 14.28; p=0.018). There were no significant differences in 90-day mortality or symptomatic hemorrhagic transformation rates. In this study, systematic use of GA for stroke EVT was associated with better clinical outcomes, higher recanalization rates, and fewer procedural complications compared with patients treated under LA as the primary anesthetic approach.

Sections du résumé

BACKGROUND BACKGROUND
To date, the choice of optimal anesthetic management during endovascular therapy (EVT) of acute ischemic stroke patients remains subject to debate. We aimed to compare functional outcomes and complication rates of EVT according to the first-line anesthetic management in two comprehensive stroke centers: local anesthesia (LA) versus general anesthesia (GA).
METHODS METHODS
Retrospective analysis of prospectively collected databases, identifying all consecutive EVT for strokes in the anterior circulation performed between January 1, 2018 and December 31, 2018 in two EVT-capable stroke centers. One center performed EVT under LA in the first intention, while the other center systematically used GA. Using propensity score analysis, the two groups underwent 1:1 matching, then procedural metrics, complications, and clinical outcomes were compared. Good outcome was defined as 90 days modified Rankin Scale (mRS) ≤2, and successful recanalization as modified Thrombolysis In Cerebral Ischemia (mTICI) 2b-3.
RESULTS RESULTS
During the study period, 219 patients were treated in the LA center and 142 in the GA center. Using the propensity score, 97 patients from each center were matched 1:1 according to the baseline characteristics. Local anesthesia was associated with a significantly lower proportion of good outcome (36.1% vs 52.0%, OR 0.53, 95% CI 0.33 to 0.87; p=0.039), lower rate of successful recanalization (70.1% vs 95.8%, OR 0.13, 95% CI 0.04 to 0.39; p<0.001), and more procedural complications (14.4% vs 3.0%, OR 3.44, 95% CI 1.09 to 14.28; p=0.018). There were no significant differences in 90-day mortality or symptomatic hemorrhagic transformation rates.
CONCLUSIONS CONCLUSIONS
In this study, systematic use of GA for stroke EVT was associated with better clinical outcomes, higher recanalization rates, and fewer procedural complications compared with patients treated under LA as the primary anesthetic approach.

Identifiants

pubmed: 32487768
pii: neurintsurg-2020-015916
doi: 10.1136/neurintsurg-2020-015916
doi:

Types de publication

Comparative Study Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

207-211

Informations de copyright

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Raoul Pop (R)

Interventional Radiology, Institut Hospitalo-Universitaire Strasbourg, Strasbourg, France pop.raoul@gmail.com.
Interventional Neuroradiology, University Hospitals Strasbourg, Strasbourg, Alsace, France.

François Severac (F)

Public Healthcare Department, University Hospitals Strasbourg, Strasbourg, Alsace, France.

Emmanuel Happi Ngankou (E)

Department of Diagnostic and Interventional Neuroradiology, University Hospital Centre Nancy, Nancy, Lorraine, France.

Oana Harsan (O)

Interventional Neuroradiology, University Hospitals Strasbourg, Strasbourg, Alsace, France.

Ioan Martin (I)

Interventional Neuroradiology, University Hospitals Strasbourg, Strasbourg, Alsace, France.

Dan Mihoc (D)

Interventional Neuroradiology, University Hospitals Strasbourg, Strasbourg, Alsace, France.

Monica Manisor (M)

Interventional Neuroradiology, University Hospitals Strasbourg, Strasbourg, Alsace, France.

Mihaela Simu (M)

Neurology, University of Medicine and Pharmacy Victor Babes Timisoara, Timisoara, Romania.

Salvatore Chibbaro (S)

Neurosurgery, University Hospitals Strasbourg, Strasbourg, Alsace, France.

Valérie Wolff (V)

Stroke Unit, University Hospitals Strasbourg, Strasbourg, Alsace, France.

Roxana Gheoca (R)

Stroke Unit, University Hospitals Strasbourg, Strasbourg, Alsace, France.

Alain Meyer (A)

Anesthesia, University Hospitals Strasbourg, Strasbourg, Alsace, France.

Julien Pottecher (J)

Anesthesia, University Hospitals Strasbourg, Strasbourg, Alsace, France.

Gérard Audibert (G)

Service d'Anesthésie-Réanimation Chirurgicale, Hôpital Central, University Hospital Centre Nancy, Nancy, Lorraine, France.
Faculte de Medecine, Universite de Lorraine, Nancy, Lorraine, France.

Anne-Laure Derelle (AL)

Department of Diagnostic and Interventional Neuroradiology, University Hospital Centre Nancy, Nancy, Lorraine, France.

Romain Tonnelet (R)

Department of Diagnostic and Interventional Neuroradiology, University Hospital Centre Nancy, Nancy, Lorraine, France.

Liang Liao (L)

Department of Diagnostic and Interventional Neuroradiology, University Hospital Centre Nancy, Nancy, Lorraine, France.

François Zhu (F)

Department of Diagnostic and Interventional Neuroradiology, University Hospital Centre Nancy, Nancy, Lorraine, France.

Serge Bracard (S)

Department of Diagnostic and Interventional Neuroradiology, University Hospital Centre Nancy, Nancy, Lorraine, France.

René Anxionnat (R)

Department of Diagnostic and Interventional Neuroradiology, University Hospital Centre Nancy, Nancy, Lorraine, France.

Sébastien Richard (S)

Faculte de Medecine, Universite de Lorraine, Nancy, Lorraine, France.
Neurology Stroke Unit, University Hospital Centre Nancy, Nancy, Lorraine, France.
U1116, INSERM, Nancy, France.

Rémy Beaujeux (R)

Interventional Radiology, Institut Hospitalo-Universitaire Strasbourg, Strasbourg, France.
Interventional Neuroradiology, University Hospitals Strasbourg, Strasbourg, Alsace, France.

Benjamin Gory (B)

Department of Diagnostic and Interventional Neuroradiology, University Hospital Centre Nancy, Nancy, Lorraine, France.
Faculte de Medecine, Universite de Lorraine, Nancy, Lorraine, France.
U1254, INSERM, Nancy, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH